Common variable immune deficiency in adults: focus on pulmonary complications

Fomina D.S.; Bobrikova E.N.; Sinyavkin D.O.; Parshin V.V.

doi:https://doi.org/10.17116/terarkh20178912211-215

Fomina D.S.

Department of Clinical Allergology, Russian Medical Academy of Continuing Postgraduate Education, Ministry of Health of Russia, Moscow, Russia;
Center of Allergology and Immunology, City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Bobrikova E.N.

Center of Allergology and Immunology, City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Sinyavkin D.O.

Center of Allergology and Immunology, City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Parshin V.V.

University's Clinical Hospital №1, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Common variable immune deficiency in adults: focus on pulmonary complications

Authors:

Fomina D.S., Bobrikova E.N., Sinyavkin D.O., Parshin V.V.

More about the authors

Journal: Therapeutic Archive. 2017;89(12): 211‑215

DOI: 10.17116/terarkh20178912211-215

Read: 5337 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Fomina DS, Bobrikova EN, Sinyavkin DO, Parshin VV. Common variable immune deficiency in adults: focus on pulmonary complications. Therapeutic Archive. 2017;89(12):211‑215. (In Russ.)
https://doi.org/10.17116/terarkh20178912211-215

Использование инфографики авторами научных работ

Close metadata

Abstract:

Common variable immune deficiency is the most common form of a group of primary immunodeficiencies in adult patients. Pulmonary complications occupy leading positions. It is the development of recurrent bronchopulmonary inflammatory diseases that is considered to be one of the main causes of death and disability in patients with this disease. By presenting two clinical cases with long diagnostic delays, the authors try to attract the attention of specialists of related professions, which will minimize the development of irreversible complications in the patients.

Keywords:

common variable immune deficiency

primary immunodeficiencies

pulmonary complications

intravenous immunoglobulins

Authors:

Fomina D.S.

Bobrikova E.N.

Center of Allergology and Immunology, City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Sinyavkin D.O.

Center of Allergology and Immunology, City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Parshin V.V.

University's Clinical Hospital №1, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

ESID Registry — Working definitions for clinical diagnosis of PID august 2016.
Latysheva EA. Primary immunodeficiency: status of a problem today. russian network of jmf-centers. Voprosy sovremennoii pediatrii. 2013;12(6):73-77. (In Russ.)
Dantas EO, Aranda CS, Nobre FA, Fahl K, et al. Medical awareness concerning primary immunodeficiency diseases in the city of São Paulo, Brazil. Journal of Allergy and Clinical Immunology 2012;129 iss 2 AB86. https://doi.org/10.1016/j.jaci.2011.12.648
Chapel Н, Prevot J, Gaspar H, Español T. Primary immune deficiencies — principles of care Frontiers in immunology. Front Immunol. 2014;5:627. https://doi.org/10.3389/fimmu.2014.00627
Kondratenko IV. Primary immunodeficiencies. Meditsinskaya Immunologiya. 2005;56(7):467-476. © 2005, SPb RO RAAKI. (In Russ.)
Liesch Z, Hаnck C, Werth B, Kuhn M, et al. Diarrhea and weight loss in common variable immunodeficiency. Z Gastroenterol. 2004;42:599-603. https://doi.org/10.1055/s-2004-813184
Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep. 2004;6:377-383. https://doi.org/10.1007/s11894-004-0053-y
Chapel H, Lucas M, Lee M, Bjorkander J, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277-286. https://doi.org/10.1182/blood-2007-11-124545
Guillaume B, Julien B. Cindy Barnig, et al. Thoracic Manifestations of Primary Humoral Immunodeficiency: A Comprehensive Review. RadioGraphics. 2009;29:1909-1920. https://doi.org/10.1148/rg.297095717
Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol. 2009;124:658-664. https://doi.org/10.1016/j.jaci.2009.06.018
Jolles S, Orange S, Gardulf A. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. British Society for Immunology. Clinical and Experimental Immunology. 2014;179:146-160. https://doi.org/10.1111/cei.12485
Cunningham — Rundles C. How I treat common variable immune deficiency. Blood .2010;116:7-15. https://doi.org/10.1182/blood-2010-01-254417
Latysheva TV, Latysheva EA, Martynova IA. A place of intravenous immunoglobulins in current clinical practice: Privigen is a novel 10% immunoglobulin. Terapevticheskii arkhiv. 2016;88(4):82-87. (In Russ.)